{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:47:23Z","timestamp":1774460843831,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/jac\/dki101","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T00:13:41Z","timestamp":1113005621000},"page":"958-964","source":"Crossref","is-referenced-by-count":32,"title":["Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998\u20132003"],"prefix":"10.1093","volume":"55","author":[{"given":"Momtaz O.","family":"Wasfy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abdel-Maksoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Barrozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Klena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Earhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Hajjeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4,8]]},"reference":[{"key":"key\n\t\t\t\t20171010140914_R1","doi-asserted-by":"crossref","unstructured":"Obaro SK, Monteil MA, Henderson DC. The pneumococcal problem. BMJ1996; 312: 1521\u20135.","DOI":"10.1136\/bmj.312.7045.1521"},{"key":"key\n\t\t\t\t20171010140914_R2","doi-asserted-by":"crossref","unstructured":"Rennels MB, Edwards KM, Keyerling HL et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics1998; 101: 604\u201311.","DOI":"10.1542\/peds.101.4.604"},{"key":"key\n\t\t\t\t20171010140914_R3","doi-asserted-by":"crossref","unstructured":"Gertz RE, McEllistrem MC, Boxrud DJ et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol2003; 4: 4194\u2013216.","DOI":"10.1128\/JCM.41.9.4194-4216.2003"},{"key":"key\n\t\t\t\t20171010140914_R4","doi-asserted-by":"crossref","unstructured":"Catterall JR. Lung infections: Streptococcus pneumoniae. Thorax1999; 54: 929\u201337.","DOI":"10.1136\/thx.54.10.929"},{"key":"key\n\t\t\t\t20171010140914_R5","doi-asserted-by":"crossref","unstructured":"Arai S, Konda T, Wad A et al. Use of antiserum-coated latex particles for serotyping Streptococcus pneumoniae. Microbiol Immunol2001; 45: 159\u201362.","DOI":"10.1111\/j.1348-0421.2001.tb01284.x"},{"key":"key\n\t\t\t\t20171010140914_R6","doi-asserted-by":"crossref","unstructured":"Choo S, Finn A. New pneumococcal vaccines for children. Arch Dis Child2001; 84: 289\u201394.","DOI":"10.1136\/adc.84.4.289"},{"key":"key\n\t\t\t\t20171010140914_R7","doi-asserted-by":"crossref","unstructured":"Robbins JB, Austrian R, Lee CJ et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis1983; 148: 1136\u201359.","DOI":"10.1093\/infdis\/148.6.1136"},{"key":"key\n\t\t\t\t20171010140914_R8","doi-asserted-by":"crossref","unstructured":"Sleeman K, Knox K, George R et al. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis2001; 183: 239\u201346.","DOI":"10.1086\/317924"},{"key":"key\n\t\t\t\t20171010140914_R9","doi-asserted-by":"crossref","unstructured":"Eby R. Pneumococcal conjugate vaccines. In: Powell MF, Newman MJ, eds. Pharmaceutical Biotechnology, Vol. 6. Vaccine design: the subunit and adjuvant approach. New York: Plenum, 1995; 695\u2013718.","DOI":"10.1007\/978-1-4615-1823-5_31"},{"key":"key\n\t\t\t\t20171010140914_R10","doi-asserted-by":"crossref","unstructured":"Black S, Shinefield H, Fireman B et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J2000; 19: 187\u201395.","DOI":"10.1097\/00006454-200003000-00003"},{"key":"key\n\t\t\t\t20171010140914_R11","doi-asserted-by":"crossref","unstructured":"Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med2003; 348: 1737\u201346.","DOI":"10.1056\/NEJMoa022823"},{"key":"key\n\t\t\t\t20171010140914_R12","doi-asserted-by":"crossref","unstructured":"Hausdorff WP, Bryant J, Peter R et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis2000; 30: 100\u201321.","DOI":"10.1086\/313608"},{"key":"key\n\t\t\t\t20171010140914_R13","doi-asserted-by":"crossref","unstructured":"Robinson KA, Baughman W, Rothrock G et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998: opportunities for prevention in the conjugate vaccine era. JAMA2001; 285: 1729\u201335.","DOI":"10.1001\/jama.285.13.1729"},{"key":"key\n\t\t\t\t20171010140914_R14","doi-asserted-by":"crossref","unstructured":"Miller E, Waight P, Efstratiou A et al. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996\u201398. Acta Paediatr2000; 89: 11\u201316.","DOI":"10.1111\/j.1651-2227.2000.tb00776.x"},{"key":"key\n\t\t\t\t20171010140914_R15","doi-asserted-by":"crossref","unstructured":"Qrtqvist A. Pneumococcal vaccination: current and future issues. Eur Respir J2001; 18: 184\u201395.","DOI":"10.1183\/09031936.01.00084401"},{"key":"key\n\t\t\t\t20171010140914_R16","doi-asserted-by":"crossref","unstructured":"Hausdorff WP, Bryant J, Kloek C et al. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis2000; 30: 122\u201340.","DOI":"10.1086\/313609"},{"key":"key\n\t\t\t\t20171010140914_R17","doi-asserted-by":"crossref","unstructured":"Whitney CG, Farley MM, Hadler J et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med2000; 343: 1917\u201324.","DOI":"10.1056\/NEJM200012283432603"},{"key":"key\n\t\t\t\t20171010140914_R18","doi-asserted-by":"crossref","unstructured":"Jacobs MR, Koornhof HJ, Robinson-Browen RM et al. Emergence of multiple resistance pneumococci. N Engl J Med1978; 299: 735\u201340.","DOI":"10.1056\/NEJM197810052991402"},{"key":"key\n\t\t\t\t20171010140914_R19","doi-asserted-by":"crossref","unstructured":"Hofmann J, Cetron MS, Farley MM et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med1995; 333: 481\u20136.","DOI":"10.1056\/NEJM199508243330803"},{"key":"key\n\t\t\t\t20171010140914_R20","doi-asserted-by":"crossref","unstructured":"Crew-Brown HH, Karstaedt AS, Saunders G et al. Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis1997; 25: 1165\u201372.","DOI":"10.1086\/516104"},{"key":"key\n\t\t\t\t20171010140914_R21","doi-asserted-by":"crossref","unstructured":"Benbachier M, Benredjeb S, Boye CS et al. Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother2001; 45: 627\u20139.","DOI":"10.1128\/AAC.45.2.627-629.2001"},{"key":"key\n\t\t\t\t20171010140914_R22","unstructured":"Guirguis N, Hafez K, El Kholy MA et al. Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977\u201378. Bull World Health Organ1983; 61: 517\u201324."},{"key":"key\n\t\t\t\t20171010140914_R23","doi-asserted-by":"crossref","unstructured":"Ajello GW, Feeley JC, Hayes PS et al. Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol1984; 20: 55\u20138.","DOI":"10.1128\/JCM.20.1.55-58.1984"},{"key":"key\n\t\t\t\t20171010140914_R24","doi-asserted-by":"crossref","unstructured":"Eskola J, Kilpi T, Palmu A et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med2001; 344: 403\u20139.","DOI":"10.1056\/NEJM200102083440602"},{"key":"key\n\t\t\t\t20171010140914_R25","doi-asserted-by":"crossref","unstructured":"Kilpi T, Ahman H, Jokinen J et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis2003; 37: 1155\u201364.","DOI":"10.1086\/378744"},{"key":"key\n\t\t\t\t20171010140914_R26","unstructured":"National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disc Susceptibility Tests-Eighth Edition: Approved Standard M2-A8. NCCLS, Wayne, PA, 2003."},{"key":"key\n\t\t\t\t20171010140914_R27","unstructured":"National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, 2003."},{"key":"key\n\t\t\t\t20171010140914_R28","doi-asserted-by":"crossref","unstructured":"Jacobs MR, Bajaksouzian S, Appelbaum PC et al. Evaluation of the Etest for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis1992; 15: 473\u20138.","DOI":"10.1016\/0732-8893(92)90093-9"},{"key":"key\n\t\t\t\t20171010140914_R29","doi-asserted-by":"crossref","unstructured":"Jacobs MR, Koornhof HJ, Robins-Browne RM et al. Emergence of multiply resistant pneumococci. N Engl J Med1978; 229: 735\u201340.","DOI":"10.1056\/NEJM197810052991402"},{"key":"key\n\t\t\t\t20171010140914_R30","doi-asserted-by":"crossref","unstructured":"Goetghebuer T, West TE, Wermenbol V et al. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Trop Med Int Health2000; 5: 207\u201313.","DOI":"10.1046\/j.1365-3156.2000.00535.x"},{"key":"key\n\t\t\t\t20171010140914_R31","doi-asserted-by":"crossref","unstructured":"Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J1993; 12: 389\u201394.","DOI":"10.1097\/00006454-199305000-00008"},{"key":"key\n\t\t\t\t20171010140914_R32","unstructured":"Guirguis NI, Helmy MF, Mohamed MR et al. A suggested vaccine formulation for the control of pneumococcal meningitis in Egypt. J Egypt Public Health Assoc1990; 65: 291\u2013303."},{"key":"key\n\t\t\t\t20171010140914_R33","doi-asserted-by":"crossref","unstructured":"Fenoll A, Jado I, Vicioso D et al. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol1998; 36: 3447\u201354.","DOI":"10.1128\/JCM.36.12.3447-3454.1998"},{"key":"key\n\t\t\t\t20171010140914_R34","doi-asserted-by":"crossref","unstructured":"Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implication for the era of pneumococcal conjugate vaccines. Clin Infect Dis2002; 35: 547\u201355.","DOI":"10.1086\/341896"},{"key":"key\n\t\t\t\t20171010140914_R35","doi-asserted-by":"crossref","unstructured":"Scott JA, Hall AJ, Dagan R et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7000 episodes of invasive disease. Clin Infect Dis1996; 22: 973\u201381.","DOI":"10.1093\/clinids\/22.6.973"},{"key":"key\n\t\t\t\t20171010140914_R36","doi-asserted-by":"crossref","unstructured":"Dagan R, Engelhard D, Piccard E. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA1992; 268: 3328\u201332.","DOI":"10.1001\/jama.268.23.3328"},{"key":"key\n\t\t\t\t20171010140914_R37","doi-asserted-by":"crossref","unstructured":"Rahav G, Toledano Y, Engelhard D et al. Invasive pneumococcal infections: a comparison between adults and children. Medicine1997; 76: 295\u2013303.","DOI":"10.1097\/00005792-199707000-00007"},{"key":"key\n\t\t\t\t20171010140914_R38","doi-asserted-by":"crossref","unstructured":"Shibl AM, Hussein SS. Surveillance of Streptococcus pneumoniae serotypes in Riyadh and their susceptibility to penicillin and other commonly prescribed antibiotics. JAC1992; 29: 149\u201357.","DOI":"10.1093\/jac\/29.2.149"},{"key":"key\n\t\t\t\t20171010140914_R39","doi-asserted-by":"crossref","unstructured":"V\u00e4kev\u00e4inen M, Eklund C, Eskola J et al. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis2001; 184: 789\u201393.","DOI":"10.1086\/322984"},{"key":"key\n\t\t\t\t20171010140914_R40","doi-asserted-by":"crossref","unstructured":"Ostroff SM, Harrison LH, Khallaf N et al. Resistance patterns of Streptococcus pneumoniae and Haemophilus influenzae isolates recovered in Egypt from children with pneumoniae. Clin Infect Dis1996; 23: 1069\u201374.","DOI":"10.1093\/clinids\/23.5.1069"},{"key":"key\n\t\t\t\t20171010140914_R41","doi-asserted-by":"crossref","unstructured":"El Kholy MA, Baseem H, Hall GS et al. Antimicrobial resistance in Cairo, Egypt 1999\u20132000: a survey of five hospitals. JAC2003; 51: 625\u201330.","DOI":"10.1093\/jac\/dkg101"},{"key":"key\n\t\t\t\t20171010140914_R42","doi-asserted-by":"crossref","unstructured":"Doern GV, Heilmann KP, Huynh HK et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995. Antimicrob Agents Chemother2001; 45: 1721\u20139.","DOI":"10.1128\/AAC.45.6.1721-1729.2001"},{"key":"key\n\t\t\t\t20171010140914_R43","doi-asserted-by":"crossref","unstructured":"Gwanzura L, Christopher P, Nathoo KJ et al. Rapid emergence of resistance to penicillin and trimethoprim-sulfamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. Int J Antimicrob Agents2003; 21: 557\u201361.","DOI":"10.1016\/S0924-8579(03)00052-9"},{"key":"key\n\t\t\t\t20171010140914_R44","doi-asserted-by":"crossref","unstructured":"Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. J Pediatr Infect Dis1991; 10: 871\u20133.","DOI":"10.1097\/00006454-199111000-00018"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/6\/958\/2155061\/dki101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:39:39Z","timestamp":1586198379000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/6\/958\/725455\/Antimicrobial-susceptibility-and-serotype"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,8]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,4,8]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki101","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,4,8]]}}}